689 related articles for article (PubMed ID: 28483542)
1. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
2. An Update on the Pathogenesis of Skin Damage in Lupus.
Li Q; Wu H; Zhou S; Zhao M; Lu Q
Curr Rheumatol Rep; 2020 May; 22(5):16. PubMed ID: 32399815
[TBL] [Abstract][Full Text] [Related]
3. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
Yazdani MR; Aflaki E; Gholijani N
Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
[TBL] [Abstract][Full Text] [Related]
5. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
Front Immunol; 2021; 12():775353. PubMed ID: 34868043
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
7. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
Robinson ES; Werth VP
Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
[TBL] [Abstract][Full Text] [Related]
9. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
10. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
11. The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.
Yu Y; Jin H; Zhou S; Zhao M; Wu H; Long H; Fu S; Wu R; Yin H; Liao J; Luo S; Liu Y; Zhang Q; Zhang P; Tan Y; Huang X; Li F; Lin G; Lu Q
Clin Rheumatol; 2023 Sep; 42(9):2353-2367. PubMed ID: 37311918
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous and systemic connections in lupus.
Maz MP; Michelle Kahlenberg J
Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
[TBL] [Abstract][Full Text] [Related]
14. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
15. Periorbital erythema and swelling as a presenting sign of lupus erythematosus in tertiary referral centers and literature review.
Wu MY; Wang CH; Ng CY; Kuo TT; Chang YC; Yang CH; Lin JY; Ho HC; Chung WH; Chen CB
Lupus; 2018 Oct; 27(11):1828-1837. PubMed ID: 30134759
[TBL] [Abstract][Full Text] [Related]
16. The gender disparity of immunoreactants in lesional skin of lupus erythematosus patients.
Yu M; Li KW; Tan GZ; Luo T; Xu DQ; Wang L
Clin Exp Rheumatol; 2012; 30(1):103-5. PubMed ID: 22260779
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
[TBL] [Abstract][Full Text] [Related]
18. Biological therapies in the treatment of cutaneous lupus erythematosus.
Presto JK; Hejazi EZ; Werth VP
Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets.
Wenzel J; Zahn S; Tüting T
Lupus; 2010 Aug; 19(9):1020-8. PubMed ID: 20693195
[TBL] [Abstract][Full Text] [Related]
20. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
Erazo-Martínez V; Tobón GJ; Cañas CA
Autoimmun Rev; 2023 Feb; 22(2):103262. PubMed ID: 36563771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]